Back
 CM  Vol.4 No.1 , March 2013
In-Vitro Inhibitory Effect of Methanol Extracts of Chinese Herbal Drugs on Supercoiling Activity of Bacterial DNA Gyrase
Abstract: A large number of Chinese herbal drugs (CHDs) exhibit antibacterial activities both in vivo and in vitro, but until now little is known regarding their inhibitory mechanisms. Bacterial DNA gyrase is a proven target for antibacterial agents. Aim of this study was to investigate the in-vitro inhibitory effect of methanol extracts of CHDs against supercoiling activity of bacterial DNA gyrase. Fifteen CHDs were selected and extracted with methanol, respectively. Inhibitory effect of the extracts on DNA gyrase was tested using gel-based DNA supercoiling assay. Among fifteen CHDs tested, methanol extracts of Lonicerae Japonicae Flos (S2), Taraxaci Herba (S7), Glycyrrhizae Radix et Rhizoma Praeparata cum Melle (S8) demonstrated an obvious inhibitory effect against supercoiling activity of DNA gyrase, and the others were either less active or could not be determined with the present method. Moreover, it was likely that S7 and S8 inhibit gyrase in a concentration-dependent manner. In conclusion, DNA supercoiling assay is a promising method to study the inhibitory activity of CHDs on bacterial DNA gyrase. Some CHDs do have gyrase-inhibitory activity as proposed. Further investigations are needed to elucidate the inhibition mechanism of these CHDs on supercoiling activity of gyrase.
Cite this paper: H. Xu, H. Chen, P. Yao, G. Lin and W. Chen, "In-Vitro Inhibitory Effect of Methanol Extracts of Chinese Herbal Drugs on Supercoiling Activity of Bacterial DNA Gyrase," Chinese Medicine, Vol. 4 No. 1, 2013, pp. 19-23. doi: 10.4236/cm.2013.41004.
References

[1]   H. H. Li and L. Ma, “Studies on the Antibacterial Effect of Chinese Medicinal Plants,” Journal of Changchun University of Traditional Chinese Medicine, Vol. 26, No. 1, 2010, pp. 136-137.

[2]   H. G. Liu, Q. R. Shen and L. M. Liu, “The Development of Traditional Chinese Medicine in Antibacteria,” Lishizhen Medicine and Materia Medica Research, Vol. 21, No. 2, 2010, pp. 463-465.

[3]   Z. P. Gou and D. G. Wan, “Antibacterial Activity of Varieties of Flos Lonicerae Produced in Sichuan in Vitro by Beating Holes Method,” Lishizhen Medicine and Materia Medica Research, Vol. 19, No. 3, 2008, pp. 724-725.

[4]   Y. B. Tian, Z. H. Chen, M. H. Yang, Y. L. Hu, Q. L. Liu and L. Z. Liu, “In Vitro Bacteriostatic Investigation of 16 Chinese Medical Formula Decoction on MRSA and MSSA,” Chinese Journal of Hospital Pharmacy, No. 11, 2009, pp. 897-899.

[5]   Y. J. Yang, Y. Q. Liu, J. F. Zhang, X. H. Huang, F. Tan, H. X. Cai, H. P. Huang and Y. Zhu, “In Vitro Antibacterial Activity of Coptidis rhizoma and Galla chinensis on VRE,” Journal of Southern Medical University, No. 5, 2008, pp. 819-820.

[6]   M. J. Chen, G. Li, L. Gu, J. Liu and S. H. Xiao, “Study on Antibacterial Effect of YINHUANG Injection in Vitro,” Lishizhen Medicine and Materia Medica Research, Vol. 18, No. 2, pp. 377-378.

[7]   F. Liu and M. R. Kong, “Overview of Antibacterial Activities of Traditional Chinese Medicine,” Chinese Journal of Ethnomedicine and Ethnopharmacy, Vol. 2, No. 19, 2010, pp. 14, 38.

[8]   J. J. Champoux, “DNA Topoisomerases: Structure, Function, and Mechanism,” Annual Review of Biochemistry, Vol. 70, 2001, pp. 369-413. doi:10.1146/annurev.biochem.70.1.369

[9]   R. J. Reece and A. Maxwell, “DNA Gyrase: Structure and Function,” Critical Reviews in Biochemistry and Molecular Biology, Vol. 26, No. 3-4, 1991, pp. 335-375. doi:10.3109/10409239109114072

[10]   K. Drlica and M. Malik, “Fluoroquinolones: Action and Resistance,” Current Topics in Medicinal Chemistry, Vol. 3, No. 3, 2003, pp. 249-282. doi:10.2174/1568026033452537

[11]   A. Maxwell, “DNA Gyrase as a Drug Target,” Biochemical Society Transactions, Vol. 27, No. 2, 1999, pp. 4853.

[12]   M. Chatterji, S. Unniraman, S. Mahadevan and V. Nagaraja, “Effect of Different Classes of Inhibitors on DNA Gyrase from Mycobacterium smegmatis,” Journal of Antimicrobial Chemotherapy, Vol. 48, No. 4, 2001, pp. 479-485. doi:10.1093/jac/48.4.479

[13]   Chinese Pharmacopoeia Commission, “Pharmacopoeia of the People’s Republic of China (Volume I),” People’s Medical Publishing House, Beijing, 2010.

[14]   T. M. Zhang, “Chinese Medica Materia,” Higher Education Press, Beijing, 2008.

 
 
Top